TIENAM

This brand name is authorized in Brazil, Cyprus, Estonia, France, Hong Kong, Japan, Lithuania, Malta, Mexico, Singapore, Turkey, South Africa

Active ingredients

The drug TIENAM contains a combination of these active pharmaceutical ingredients (APIs):

1 Imipemide UNII 71OTZ9ZE0A - IMIPENEM

Imipenem is a semi-synthetic derivative of thienamycin, the parent compound produced by the filamentous bacterium Streptomyces cattleya. Imipenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs). Read about Imipemide

2 Cilastatin UNII 141A6AMN38 - CILASTATIN

Read about Cilastatin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DH51	Imipenem and enzyme inhibitor	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525502206151317
Country: EE	Ravimiamet	Identifier(s): 1331345, 1331356, 1624205
Country: FR	Base de données publique des médicaments	Identifier(s): 69552232
Country: HK	Department of Health Drug Office	Identifier(s): 28979
Country: JP	医薬品医療機器総合機構	Identifier(s): 6139501D2105, 6139501E2038, 6139501G1067
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1033350, 1033351, 1066700
Country: MT	Medicines Authority	Identifier(s): AA565/77801
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 180M87
Country: SG	Health Sciences Authority	Identifier(s): 00706P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636260104, 8699636260111
Country: ZA	Health Products Regulatory Authority	Identifier(s): S/20.1.1/175